MarkWide Research

All our reports can be tailored to meet our clients’ specific requirements, including segments, key players and major regions,etc.

Global Peripheral Intervention Drug-Eluting Devices Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2025-2034

Global Peripheral Intervention Drug-Eluting Devices Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2025-2034

Published Date: May, 2025
Base Year: 2024
Delivery Format: PDF+Excel, PPT
Historical Year: 2018-2023
No of Pages: 263
Forecast Year: 2025-2034

ย  ย  Corporate User Licenseย 

Unlimited User Access, Post-Sale Support, Free Updates, Reports in English & Major Languages, and more

$3450

Market Overview

The global peripheral intervention drug-eluting devices market is experiencing significant growth and is expected to continue expanding in the coming years. These devices play a crucial role in the treatment of peripheral artery disease (PAD) by delivering drugs directly to the affected arteries, preventing restenosis and reducing the need for repeated interventions. This market analysis provides an in-depth understanding of the current trends, key drivers, restraints, and opportunities shaping the peripheral intervention drug-eluting devices market.

Meaning

Peripheral intervention drug-eluting devices refer to specialized medical devices used in the treatment of peripheral artery disease. These devices are designed to be implanted in narrowed or blocked arteries to restore blood flow and deliver therapeutic drugs to prevent the recurrence of blockages. By combining the benefits of drug therapy and interventional procedures, these devices offer improved outcomes and reduce the need for repeated interventions.

Executive Summary

The executive summary provides a concise overview of the key findings and insights from the analysis of the global peripheral intervention drug-eluting devices market. It highlights the market’s growth potential, key market drivers, restraints, and opportunities, along with a brief summary of the regional analysis and competitive landscape.

Global Peripheral Intervention Drug-Eluting Devices Market Key Players

Important Note: The companies listed in the image above are for reference only. The final study will cover 18โ€“20 key players in this market, and the list can be adjusted based on our clientโ€™s requirements.

Key Market Insights

  • Rising Incidence of Peripheral Artery Diseases: The growing prevalence of PAD due to risk factors such as diabetes, hypertension, smoking, and aging is driving demand for effective treatment options, particularly drug-eluting devices.
  • Minimally Invasive Procedures: The growing preference for minimally invasive surgical procedures, which involve shorter recovery times and reduced complications, is a key driver of the market.
  • Technological Advancements: Continuous innovations in drug-eluting technologies, such as the development of next-generation stents and drug coatings, are improving the effectiveness of peripheral interventions.
  • Regulatory Approvals: The increasing number of regulatory approvals for new drug-eluting devices, coupled with expanding indications for their use, is contributing to the market’s growth.

Market Drivers

Several key factors are fueling the growth of the Global Peripheral Intervention Drug-Eluting Devices Market:

  1. Increasing Prevalence of Peripheral Artery Diseases (PAD): The aging global population and increasing rates of lifestyle-related diseases such as diabetes and hypertension are major contributors to the rising incidence of PAD, which in turn drives demand for effective treatments.
  2. Shift Toward Minimally Invasive Procedures: Patients and healthcare providers are increasingly opting for minimally invasive interventions that offer faster recovery and reduced risks. Drug-eluting devices, particularly drug-eluting stents and balloons, are becoming the preferred option in these procedures.
  3. Technological Advancements: Innovations in drug delivery mechanisms, coatings, and stent designs have enhanced the efficacy of peripheral interventions, minimizing the risk of restenosis and improving long-term outcomes.
  4. Growing Geriatric Population: The global increase in the geriatric population is driving demand for peripheral interventions, as elderly individuals are at higher risk of PAD and related complications.
  5. Increasing Awareness and Access to Healthcare: As awareness about PAD grows and healthcare access improves, more patients are seeking treatment options, contributing to the market’s growth.

Market Restraints

Despite its promising growth, the Global Peripheral Intervention Drug-Eluting Devices Market faces several challenges:

  1. High Costs of Treatment: Drug-eluting devices, particularly advanced stents and balloons, can be expensive, which may limit their adoption, especially in cost-sensitive regions and among underinsured patient populations.
  2. Regulatory Hurdles: The approval process for medical devices, particularly drug-eluting devices, is stringent and time-consuming. Obtaining regulatory approval for new devices or new drug formulations can be a significant barrier to entry for manufacturers.
  3. Potential for Adverse Effects: While drug-eluting devices reduce the risk of restenosis, they may still present potential risks, such as thrombosis or allergic reactions to the drug coatings, which can raise concerns among healthcare providers.
  4. Lack of Skilled Professionals: The successful deployment of these advanced devices requires highly skilled professionals in interventional cardiology and radiology. The shortage of such skilled personnel in certain regions may hinder market growth.

Market Opportunities

The Global Peripheral Intervention Drug-Eluting Devices Market presents several opportunities for growth and innovation:

  1. Development of Next-Generation Drug-Eluting Devices: There is significant opportunity for innovation in drug-eluting devices, such as developing stents with more effective drugs, longer-lasting coatings, and improved biocompatibility.
  2. Expanding Market in Emerging Economies: As healthcare access improves in emerging markets, particularly in Asia-Pacific and Latin America, there is considerable potential for market growth. Increased investment in healthcare infrastructure will drive demand for peripheral intervention devices in these regions.
  3. Regulatory Approvals and New Indications: As regulatory agencies approve new drug-eluting devices and expand their indications for use, the market will see increased adoption of these devices in peripheral artery interventions.
  4. Partnerships and Collaborations: Strategic collaborations between device manufacturers, pharmaceutical companies, and healthcare providers can lead to the development of novel drug-eluting technologies and greater market penetration.

Global Peripheral Intervention Drug-Eluting Devices Market Segmentation

Market Dynamics

The Global Peripheral Intervention Drug-Eluting Devices Market is influenced by several dynamic factors:

  1. Technological Advancements: Innovations in drug-eluting technology, such as bioresorbable drug-eluting devices and next-generation stents, are driving the market by offering enhanced performance and safety.
  2. Healthcare System Upgrades: Healthcare systems, particularly in developing regions, are becoming more advanced, with an increased focus on treating cardiovascular diseases and expanding access to cutting-edge medical devices.
  3. Patient-Centered Care: As patient care continues to shift toward outcomes-based models, there is increasing demand for devices that provide long-term benefits and reduced risks, such as drug-eluting devices.
  4. Regulatory and Reimbursement Factors: Approval by regulatory bodies such as the FDA and EMA and the availability of reimbursement for peripheral interventions will significantly impact the market’s growth.

Regional Analysis

The Global Peripheral Intervention Drug-Eluting Devices Market exhibits regional differences in adoption, with key markets being:

  1. North America: North America holds the largest market share, driven by a high prevalence of PAD, advanced healthcare infrastructure, and the strong adoption of drug-eluting devices in interventional procedures.
  2. Europe: Europe is a key market, benefiting from regulatory approvals for advanced drug-eluting devices and a strong healthcare system that supports the adoption of cutting-edge technologies in PAD treatment.
  3. Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in the market, driven by the rising prevalence of cardiovascular diseases, improving healthcare infrastructure, and increasing awareness about PAD and its treatments.
  4. Latin America and the Middle East & Africa: Both regions are expected to see significant growth due to improved healthcare access, growing disposable incomes, and increasing adoption of advanced medical devices.

Competitive Landscape

Leading Companies in the Global Peripheral Intervention Drug-Eluting Devices Market:

  1. Medtronic plc
  2. Abbott Laboratories
  3. Boston Scientific Corporation
  4. Becton, Dickinson and Company
  5. Terumo Corporation
  6. Cook Medical Inc.
  7. Cardinal Health, Inc.
  8. C. R. Bard, Inc. (BD)
  9. Johnson & Johnson Services, Inc.
  10. Olympus Corporation

Please note: This is a preliminary list; the final study will feature 18โ€“20 leading companies in this market. The selection of companies in the final report can be customized based on our client’s specific requirements.

Segmentation

The Global Peripheral Intervention Drug-Eluting Devices Market can be segmented based on various factors:

  1. By Product Type: Drug-Eluting Stents, Drug-Eluting Balloons, Others.
  2. By Application: Coronary Artery Disease, Peripheral Artery Disease, Other Vascular Conditions.
  3. By End-user: Hospitals, Ambulatory Surgical Centers, Clinics, Others.

Category-wise Insights

Each category of drug-eluting devices offers unique benefits and is tailored to different clinical needs:

  • Drug-Eluting Stents: These devices are widely used in peripheral artery interventions and are designed to deliver medication directly to the site of arterial injury, reducing the chances of restenosis.
  • Drug-Eluting Balloons: These devices offer an alternative to stents and are typically used in cases where stents may not be appropriate or effective, particularly in smaller arteries or complex lesions.

Key Benefits for Industry Participants and Stakeholders

The Global Peripheral Intervention Drug-Eluting Devices Market offers significant benefits for industry participants:

  1. Improved Patient Outcomes: Drug-eluting devices help reduce restenosis, minimizing the need for repeat procedures and improving long-term patient outcomes.
  2. Technological Innovation: Manufacturers are able to differentiate themselves by continuously innovating, such as developing drug-eluting devices with more effective drug delivery systems and longer-lasting coatings.
  3. Expanding Market Reach: There is ample opportunity for market expansion, particularly in emerging economies where healthcare access is improving, and the adoption of advanced medical technologies is increasing.

SWOT Analysis

Strengths:

  • High efficacy in reducing restenosis.
  • Continuous advancements in device technology and drug formulations.
  • Strong demand in minimally invasive procedures.

Weaknesses:

  • High cost of drug-eluting devices.
  • Regulatory and compliance challenges.
  • Limited access in some low-income regions.

Opportunities:

  • Growing geriatric population and PAD incidence.
  • Expansion in emerging markets.
  • Technological advancements in drug-eluting coatings and materials.

Threats:

  • Competition from alternative vascular intervention therapies.
  • Economic downturns affecting healthcare spending.
  • Risk of adverse effects associated with drug-eluting devices.

Market Key Trends

Key trends influencing the Global Peripheral Intervention Drug-Eluting Devices Market include:

  1. Advancements in Drug-Eluting Technologies: The development of next-generation drug-eluting stents and balloons with enhanced drug delivery mechanisms is a major market trend.
  2. Minimally Invasive Procedures: The shift toward minimally invasive peripheral interventions continues to drive the demand for drug-eluting devices, which offer better patient outcomes and faster recovery.

Covid-19 Impact

The Covid-19 pandemic significantly impacted elective procedures, including peripheral interventions, leading to a temporary slowdown in the market. However, as healthcare systems recover, there is a resurgence in the demand for drug-eluting devices, driven by the rising prevalence of PAD and the continued shift towards minimally invasive treatments.

Key Industry Developments

Recent developments in the market include:

  1. Regulatory Approvals: The approval of new drug-eluting devices by global regulatory bodies such as the FDA and EMA, expanding the scope of these devices in treating PAD and other vascular conditions.
  2. Technological Advancements: Introduction of bioresorbable drug-eluting devices and innovations in drug coatings to improve the performance and safety of these interventions.

Analyst Suggestions

Analysts suggest that stakeholders should focus on:

  1. Innovative Product Development: Focus on creating advanced drug-eluting devices with better drug delivery systems, biocompatibility, and longer-lasting effects.
  2. Expand Market Reach: Target emerging markets where PAD incidence is rising, and healthcare access is improving.

Future Outlook

The future outlook section provides insights into the projected growth and opportunities in the peripheral intervention drug-eluting devices market. It discusses the market’s potential, emerging trends, technological advancements, and regulatory landscape. This section assists market players in understanding the future prospects and devising long-term strategies.

Conclusion

The conclusion summarizes the key findings of the market analysis and provides a comprehensive overview of the peripheral intervention drug-eluting devices market. It emphasizes the market’s growth potential, key market drivers, restraints, and opportunities. This analysis aims to guide industry participants and stakeholders in making informed decisions and capitalizing on the market’s growth opportunities.

What is Peripheral Intervention Drug-Eluting Devices?

Peripheral Intervention Drug-Eluting Devices are medical devices used in minimally invasive procedures to deliver therapeutic agents directly to the site of intervention, primarily in vascular treatments. These devices are designed to improve patient outcomes by reducing the risk of restenosis and enhancing healing.

What are the key players in the Global Peripheral Intervention Drug-Eluting Devices Market?

Key players in the Global Peripheral Intervention Drug-Eluting Devices Market include Boston Scientific, Medtronic, Abbott Laboratories, and Cook Medical, among others. These companies are known for their innovative technologies and extensive product portfolios in the field of vascular interventions.

What are the growth factors driving the Global Peripheral Intervention Drug-Eluting Devices Market?

The Global Peripheral Intervention Drug-Eluting Devices Market is driven by factors such as the increasing prevalence of peripheral artery disease, advancements in medical technology, and a growing preference for minimally invasive procedures. Additionally, the rising geriatric population contributes to the demand for these devices.

What challenges does the Global Peripheral Intervention Drug-Eluting Devices Market face?

The Global Peripheral Intervention Drug-Eluting Devices Market faces challenges such as stringent regulatory requirements, high costs associated with advanced technologies, and the risk of complications during procedures. These factors can hinder market growth and adoption rates.

What opportunities exist in the Global Peripheral Intervention Drug-Eluting Devices Market?

Opportunities in the Global Peripheral Intervention Drug-Eluting Devices Market include the development of next-generation devices with improved efficacy and safety profiles, expansion into emerging markets, and increasing collaborations between companies for research and development. These factors are expected to enhance market potential.

What trends are shaping the Global Peripheral Intervention Drug-Eluting Devices Market?

Trends shaping the Global Peripheral Intervention Drug-Eluting Devices Market include the integration of advanced materials for drug delivery, the rise of bioresorbable stents, and the growing emphasis on personalized medicine. These innovations are expected to transform treatment approaches in peripheral interventions.

Global Peripheral Intervention Drug-Eluting Devices Market

Segmentation Details
By Product Coronary Stents, Peripheral Stents, Drug-Eluting Balloons, Others
By End-User Hospitals, Ambulatory Surgical Centers, Others
By Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Please note: The segmentation can be entirely customized to align with our client’s needs.

Leading Companies in the Global Peripheral Intervention Drug-Eluting Devices Market:

  1. Medtronic plc
  2. Abbott Laboratories
  3. Boston Scientific Corporation
  4. Becton, Dickinson and Company
  5. Terumo Corporation
  6. Cook Medical Inc.
  7. Cardinal Health, Inc.
  8. C. R. Bard, Inc. (BD)
  9. Johnson & Johnson Services, Inc.
  10. Olympus Corporation

Please note: This is a preliminary list; the final study will feature 18โ€“20 leading companies in this market. The selection of companies in the final report can be customized based on our client’s specific requirements.

North America
o US
o Canada
o Mexico

Europe
o Germany
o Italy
o France
o UK
o Spain
o Denmark
o Sweden
o Austria
o Belgium
o Finland
o Turkey
o Poland
o Russia
o Greece
o Switzerland
o Netherlands
o Norway
o Portugal
o Rest of Europe

Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Kazakhstan
o Taiwan
o Vietnam
o Thailand
o Philippines
o Singapore
o Australia
o New Zealand
o Rest of Asia Pacific

South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America

The Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Israel
o Kuwait
o Oman
o North Africa
o West Africa
o Rest of MEA

What This Study Covers

  • โœ” Which are the key companies currently operating in the market?
  • โœ” Which company currently holds the largest share of the market?
  • โœ” What are the major factors driving market growth?
  • โœ” What challenges and restraints are limiting the market?
  • โœ” What opportunities are available for existing players and new entrants?
  • โœ” What are the latest trends and innovations shaping the market?
  • โœ” What is the current market size and what are the projected growth rates?
  • โœ” How is the market segmented, and what are the growth prospects of each segment?
  • โœ” Which regions are leading the market, and which are expected to grow fastest?
  • โœ” What is the forecast outlook of the market over the next few years?
  • โœ” How is customer demand evolving within the market?
  • โœ” What role do technological advancements and product innovations play in this industry?
  • โœ” What strategic initiatives are key players adopting to stay competitive?
  • โœ” How has the competitive landscape evolved in recent years?
  • โœ” What are the critical success factors for companies to sustain in this market?

Why Choose MWR ?

Trusted by Global Leaders
Fortune 500 companies, SMEs, and top institutions rely on MWRโ€™s insights to make informed decisions and drive growth.

ISO & IAF Certified
Our certifications reflect a commitment to accuracy, reliability, and high-quality market intelligence trusted worldwide.

Customized Insights
Every report is tailored to your business, offering actionable recommendations to boost growth and competitiveness.

Multi-Language Support
Final reports are delivered in English and major global languages including French, German, Spanish, Italian, Portuguese, Chinese, Japanese, Korean, Arabic, Russian, and more.

Unlimited User Access
Corporate License offers unrestricted access for your entire organization at no extra cost.

Free Company Inclusion
We add 3โ€“4 extra companies of your choice for more relevant competitive analysis โ€” free of charge.

Post-Sale Assistance
Dedicated account managers provide unlimited support, handling queries and customization even after delivery.

Client Associated with us

QUICK connect

GET A FREE SAMPLE REPORT

This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

ISO AND IAF CERTIFIED

Client Testimonials

GET A FREE SAMPLE REPORT

This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

ISO AND IAF CERTIFIED

error: Content is protected !!
Scroll to Top

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF
This website is safe and your personal information will be secured. Privacy Policy
Customize This Study
This website is safe and your personal information will be secured. Privacy Policy
Speak to Analyst
This website is safe and your personal information will be secured. Privacy Policy

Download Free Sample PDF